HLA-C and neoplasm: The efficacy of inducing an antitumor immune response depends on the major histocompatibility complex (MHC) presentation of tumor-specific antigens, as well as on the ability of the immune system to recognize these antigens as “non-self” and initiate a durable tumor-specific response (1).